default author photo

Camille Kurtz

Université Paris Cité

85 boulevard Saint-Germain

Paris, 75006

France

SCHOLARLY PAPERS

1

DOWNLOADS

139

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Pembrolizumab in Combination with CAPOX and Bevacizumab in Patients with Microsatellite Stable Metastatic Colorectal Cancer and a High Immune Infiltrate: Preliminary Results of the Single-Arm, Phase II, Open-Label FFCD 1703-POCHI Trial

Number of pages: 23 Posted: 09 Dec 2024
Université de Poitiers - Gastroenterology Department, Assistance Publique-Hôpitaux de Paris - Department of Pathology, Ambroise Paré, Saint-Malo Hospital Centre, University of Franche-Comté, Hôpital Saint Joseph, Centre François Baclesse, University of Limoges, Centre Hospitalier Général de Quimper, Hôpital Franco-Britannique, Perpignan Hospital Center, Infirmerie Protestante, Caluire et Cuire, Roche-Sur-Yon Hospital, Université de Rennes 1 - CHU de Rennes, Sainte Catherine Institute, Hôpital Franco-Britannique, University of Lorraine - Department of Hepatogastroenterology, University of Franche-Comté, Universite Paris Descartes, Université Paris VI Pierre et Marie Curie - Immunity & Cancer, Assistance Publique-Hopitaux de Paris (AP-HP) - Hôpital Européen Georges Pompidou, Université Paris Cité, Université Paris Cité, Clinique Saint Anne, Université Paris Cité and Independent
Downloads 139 (530,816)

Abstract:

Loading...

colorectal cancer, immune score, adenocarcinoma, chemotherapy, immune checkpoint inhibitor